" class="no-js "lang="en-US"> News Archives - Page 3 of 267 - Medtech Alert
Wednesday, December 06, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

InnoCan Pharma Submits New Patent Applications for Advanced Pain Relief Technology

InnoCan Pharma, a pharmaceutical technology company leveraging its novel cannabis-based therapeutics portfolio of targeted healing […]

Modus Therapeutics Presented New Data on Anemia Treatment

Modus Therapeutics, a company developing innovative treatments for patients with major unmet medical needs, announces […]

Genezen Announces the Appointment of Key Executive Leaders, Expanding Viral Vector Capabilities

Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO), today announced the […]

NIH Approves Second Phase of Funding to Support IND-enabling Work for Ambulero Gene Therapy to Treat Vascular Disease

Ambulero is developing a first-in-class gene and cell therapy platform for treating serious vascular diseases […]

Lantern Pharma Receives FDA Clearance of IND Application for Drug Candidate LP-184 in Solid Tumors

Lantern Pharma, an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary […]

BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution

BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the […]

Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy

Charles River Laboratories International and Curigin, a Korean biotechnology company developing innovative oncolytic ribonucleic acid […]

SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland

SOMAÍ Pharmaceuticals has entered into a two-year supply agreement with a well-respected Polish distributor Cosma […]

FDA Advisory Committee Votes Unanimously to Confirm Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Early Alzheimer's Disease

BioArctic AB‘s partner Eisai announced that the US Food and Drug Administration’s (FDA) Peripheral and […]

Intellia Therapeutics Announces New Positive Clinical Data from Study of an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema

Intellia Therapeutics, a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more